These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 23516870)

  • 1. [Effect of body mass reduction on the level of adiponectin in patients with obesity and type 2 diabetes mellitus].
    Roĭtman AP; Dolgov VV; Selivanova AV; Iakovlev VN
    Klin Med (Mosk); 2012; 90(12):46-7. PubMed ID: 23516870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adiponectin and E-selectin concentrations in relation to inflammation in obese type 2 diabetic patients with coronary heart disease(s).
    El-Mesallamy HO; Hamdy NM; Salman TM; Mahmoud S
    Minerva Endocrinol; 2011 Sep; 36(3):163-70. PubMed ID: 22019747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Similar to adiponectin, serum levels of osteoprotegerin are associated with obesity in healthy subjects.
    Ashley DT; O'Sullivan EP; Davenport C; Devlin N; Crowley RK; McCaffrey N; Moyna NM; Smith D; O'Gorman DJ
    Metabolism; 2011 Jul; 60(7):994-1000. PubMed ID: 21087777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of body fat composition and serum adiponectin levels in diabetic obesity and non-diabetic obesity.
    Kim C; Park J; Park J; Kang E; Ahn C; Cha B; Lim S; Kim K; Lee H
    Obesity (Silver Spring); 2006 Jul; 14(7):1164-71. PubMed ID: 16899797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes.
    Mojiminiyi OA; Abdella NA; Al Arouj M; Ben Nakhi A
    Int J Obes (Lond); 2007 Feb; 31(2):213-20. PubMed ID: 16755284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease.
    Klein S; Fontana L; Young VL; Coggan AR; Kilo C; Patterson BW; Mohammed BS
    N Engl J Med; 2004 Jun; 350(25):2549-57. PubMed ID: 15201411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Body fat mass distribution. Influence on metabolic and atherosclerotic parameters in non-insulin dependent diabetics and obese subjects with and without impaired glucose tolerance. Influence of weight reduction.
    Van Gaal L
    Verh K Acad Geneeskd Belg; 1989; 51(1):47-80. PubMed ID: 2800685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Impact of body weight loss on the concentration of adiponectin in patients with obesity and type 2 diabetes].
    Fedorova MM
    Klin Lab Diagn; 2009 Aug; (8):10-1. PubMed ID: 19824405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Leptin to adiponectin ratio, as an index of insulin resistance and atherosclerosis development].
    Kieć-Klimczak M; Malczewska-Malec M; Huszno B
    Przegl Lek; 2008; 65(12):844-9. PubMed ID: 19441676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoadiponectinemia plays a crucial role in the development of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus independent of visceral adipose tissue.
    Yoneda M; Iwasaki T; Fujita K; Kirikoshi H; Inamori M; Nozaki Y; Maeyama S; Wada K; Saito S; Terauchi Y; Nakajima A
    Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S15-21. PubMed ID: 17331160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity.
    Hung J; McQuillan BM; Thompson PL; Beilby JP
    Int J Obes (Lond); 2008 May; 32(5):772-9. PubMed ID: 18253163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Weight loss increased serum adiponectin but decreased lipid levels in obese subjects whose body mass index was lower than 30 kg/m².
    Lang HF; Chou CY; Sheu WH; Lin JY
    Nutr Res; 2011 May; 31(5):378-86. PubMed ID: 21636016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum visfatin is associated with type 2 diabetes mellitus independent of insulin resistance and obesity.
    Esteghamati A; Alamdari A; Zandieh A; Elahi S; Khalilzadeh O; Nakhjavani M; Meysamie A
    Diabetes Res Clin Pract; 2011 Feb; 91(2):154-8. PubMed ID: 21122936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of obesity on secretion of adiponectin multimeric isoforms differs in visceral and subcutaneous adipose tissue.
    Kovacova Z; Tencerova M; Roussel B; Wedellova Z; Rossmeislova L; Langin D; Polak J; Stich V
    Int J Obes (Lond); 2012 Oct; 36(10):1360-5. PubMed ID: 22143618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender differences in association of plasma adiponectin with obesity reflect resultant insulin resistance in non-diabetic Japanese patients with schizophrenia.
    Matsuda Y; Tanioka T; Yoshioka T; Nagano T; Hiroi T; Yoshikawa K; Okabe K; Nagamine I; Takasaka Y
    Psychiatry Clin Neurosci; 2005 Jun; 59(3):266-73. PubMed ID: 15896219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low plasma leptin levels in well controlled type 2 diabetes are not related to body fat mass and whole-body insulin resistance.
    Annuzzi G; Giacco R; Patti L; Bozzetto L; Viscovo D; Rivellese AA
    Nutr Metab Cardiovasc Dis; 2008 Sep; 18(7):e35-6. PubMed ID: 18472406
    [No Abstract]   [Full Text] [Related]  

  • 17. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
    Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
    Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serum adiponectin concentration in relation to body fat distribution and tissue insulin sensitivity in the glucose clamp study].
    Chen L; Xiang KS; Jia WP; Lu JX; Bao YQ; Lu HJ
    Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(21):1456-9. PubMed ID: 16061021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postprandial chylomicrons and adipose tissue lipoprotein lipase are altered in type 2 diabetes independently of obesity and whole-body insulin resistance.
    Annuzzi G; Giacco R; Patti L; Di Marino L; De Natale C; Costabile G; Marra M; Santangelo C; Masella R; Rivellese AA
    Nutr Metab Cardiovasc Dis; 2008 Oct; 18(8):531-8. PubMed ID: 18321693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance training improves cardiovascular risk factors in obese women despite a significative decrease in serum adiponectin levels.
    Ibáñez J; Izquierdo M; Martínez-Labari C; Ortega F; Grijalba A; Forga L; Idoate F; García-Unciti M; Fernández-Real JM; Gorostiaga EM
    Obesity (Silver Spring); 2010 Mar; 18(3):535-41. PubMed ID: 19713947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.